Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Morgan Stanley Maintains Overweight on Sensata Technologies, Lowers Price Target to $71

Morgan Stanley analyst Craig Hettenbach maintains Sensata Technologies (NYSE:ST) with a Overweight and lowers the price target from $75 to $71.

byBenzinga Newsdesk

February 2, 2022

1 minute read

Morgan Stanley analyst Craig Hettenbach maintains Sensata Technologies (NYSE:ST) with a Overweight and lowers the price target from $75 to $71.

Benchmark Initiates Coverage On Janus Intl Gr with Buy Rating, Announces Price Target of $18

By Benzinga Newsdesk

Today, 2:14 AM

Benchmark analyst Reuben Garner initiates coverage on Janus Intl Gr (NYSE:JBI) with a Buy rating and announces Price Target of $18.

JBI

Keybanc Upgrades First Solar to Overweight, Announces $145 Price Target

By Benzinga Newsdesk

Today, 2:14 AM

Keybanc analyst Sophie Karp upgrades First Solar (NASDAQ:FSLR) from Sector Weight to Overweight and announces $145 price target.

FSLR

Citius Pharmaceuticals Q3 EPS $(0.05) Up From $(0.11) YoY

By Benzinga Newsdesk

Today, 2:14 AM

Citius Pharmaceuticals (NASDAQ:CTXR) reported quarterly losses of $(0.05) per share. This is a 54.55 percent increase over losses of $(0.11) per share from the same period last year.

CTXR

JP Morgan Upgrades Pernod Ricard to Overweight

By Benzinga Newsdesk

Today, 2:14 AM

JP Morgan analyst Celine Pannuti upgrades Pernod Ricard (OTC:PDRDY) from Neutral to Overweight.

PDRDY

Morgan Stanley Maintains Overweight on Sensata Technologies, Lowers Price Target to $71

Related Posts

Benchmark Initiates Coverage On Janus Intl Gr with Buy Rating, Announces Price Target of $18

Keybanc Upgrades First Solar to Overweight, Announces $145 Price Target

Citius Pharmaceuticals Q3 EPS $(0.05) Up From $(0.11) YoY

JP Morgan Upgrades Pernod Ricard to Overweight